A patient with diabetic neuropathy reports a burning, electrical-type pain in the lower extremities that is worse at night and not responding to nonsteroidal anti-inflammatory drugs. Which medication will the nurse advocate for first?

Choice A reason: Hydromorphone is an opioid analgesic used for acute severe pain. Neuropathic pain does not respond well to opioids, and their use carries risks of tolerance, dependence, and side effects. Therefore, hydromorphone is not the first-line treatment for diabetic neuropathy. Choice B reason: Lorazepam is a benzodiazepine used for anxiety and sedation. It does not address neuropathic pain mechanisms and would not relieve the burning, electrical-type pain described. Using lorazepam would be inappropriate in this context. Choice C reason: Corticosteroids are anti-inflammatory agents used for conditions involving inflammation and immune response. Diabetic neuropathy is caused by nerve damage due to chronic hyperglycemia, not inflammation. Corticosteroids would not be effective for neuropathic pain management. Choice D reason: Gabapentin is an anticonvulsant that is highly effective for neuropathic pain. It works by modulating calcium channels in the nervous system, reducing abnormal nerve firing that causes burning and electrical sensations. Gabapentin is considered a first-line medication for diabetic neuropathy, especially when NSAIDs are ineffective. This makes it the most appropriate choice.